Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LACOSAMIDE INJECTION safely and effectively. See full prescribing information for LACOSAMIDE INJECTION. LACOSAMIDE injection, for intravenous use, CV Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Lacosamide injection is indicated for the treatment of partial-onset seizures in patients 17 years of age and older. Pediatric use information is approved for UCB, Inc.’s VIMPAT® (lacosamide) injection. However, due to UCB, Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
- generic_name
- lacosamide
- product_names
- LACOSAMIDE
- ndc
- 69543-455, 69543-455-20, 69543-455-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en